HESKA CORP Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss after equity in losses from unconsolidated affiliates
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Depreciation and amortization
Non-cash impact of operating leases
Deferred income tax benefit
Stock-based compensation
Provision for credit losses on convertible note receivable
Equity in losses of unconsolidated affiliates
Accretion of discounts and issuance costs
Accretion of non-controlling interest
Unrealized foreign currency transaction loss on purchase consideration payable
Provision for credit losses
Other losses (gains)
Changes in operating assets and liabilities (net of effect of acquisitions):
Accounts receivable
Inventories
Due from related parties
Lease receivable, current
Lease receivables
Other assets
Accounts payable
Accrued liabilities and other
Lease receivable, non-current
Other non-current assets
Deferred revenue and other
Due to related parties
Other liabilities

Net cash (used in) provided by operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from sale of equity investment
Cash acquired from acquisition of CVM
Investment in subsidiary, net of cash acquired
Acquisition of scil, net of cash acquired
VetZ GmbH
Biotech Laboratories U.S.A. LLC
BiEsseA s.r.1.
Lacuna Diagnostics, Inc.
Scil Animal Care Company
CVM
Acquisition of intangible asset
Investments in unconsolidated affiliates
Promissory note receivable issuance
CVM
Total promissory note receivable issuance
Real estate asset acquisition
Convertible note receivable issuance
Purchase of minority interest
Purchases of property and equipment
Proceeds from disposition of property and equipment
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock
Payments for taxes related to shares withheld for employee taxes
Payment of stock issuance costs
Proceeds from issuance of preferred stock
Distributions to non-controlling interest members
Convertible debt proceeds
Payments of related party debts
Borrowings on line of credit and other debts
Repayments of line of credit borrowings and other debts
Borrowings of other debts
Repayments of other debt
Notes Payable
Net cash (used in) provided by financing activities
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
Cash and cash equivalents
FOREIGN EXCHANGE EFFECT ON CASH AND CASH EQUIVALENTS
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR
CASH AND CASH EQUIVALENTS, END OF YEAR
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Non-cash transfers of equipment between inventory and property and equipment, net
Non-cash conversion of preferred stock to common stock
Contingent Consideration For Acquisitions
Note Payable Issued In Acquisition
Other Significant Noncash Transaction, Value of Consideration Given
Indemnity Holdback For Acquisition
Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued, Value

Comments